IRIS
COSTA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.811
NA - Nord America 3.226
AS - Asia 2.055
SA - Sud America 642
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 86
OC - Oceania 1
Totale 10.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.105
RU - Federazione Russa 2.235
SG - Singapore 881
BR - Brasile 531
CN - Cina 450
IE - Irlanda 410
IT - Italia 355
HK - Hong Kong 258
SE - Svezia 229
VN - Vietnam 165
DE - Germania 133
FR - Francia 87
FI - Finlandia 71
IN - India 67
GB - Regno Unito 65
PL - Polonia 63
CA - Canada 50
AT - Austria 47
BD - Bangladesh 44
AR - Argentina 38
MX - Messico 37
MA - Marocco 24
TR - Turchia 24
ES - Italia 23
ID - Indonesia 23
NL - Olanda 20
ZA - Sudafrica 20
EC - Ecuador 18
IQ - Iraq 18
UA - Ucraina 18
UZ - Uzbekistan 18
CO - Colombia 17
BE - Belgio 14
MY - Malesia 14
JP - Giappone 13
PK - Pakistan 13
JM - Giamaica 11
TN - Tunisia 10
EG - Egitto 9
KE - Kenya 9
LT - Lituania 9
PY - Paraguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
BO - Bolivia 6
CL - Cile 6
CR - Costa Rica 6
NP - Nepal 6
IL - Israele 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
SA - Arabia Saudita 5
SN - Senegal 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
AL - Albania 3
BB - Barbados 3
DK - Danimarca 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
DZ - Algeria 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
MT - Malta 2
NG - Nigeria 2
PS - Palestinian Territory 2
SV - El Salvador 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
RO - Romania 1
Totale 9.819
Salva come PNG Salva come JPEG
Città #
Moscow 654
Ashburn 618
Singapore 434
Dublin 410
Dallas 280
San Jose 257
Hong Kong 253
Chandler 186
Nyköping 165
Council Bluffs 124
Messina 114
Beijing 107
The Dalles 92
Los Angeles 82
Ho Chi Minh City 66
Warsaw 59
Munich 57
New York 57
Santa Clara 53
São Paulo 47
Lauterbourg 45
Rome 35
Hanoi 34
Dearborn 31
Vienna 30
Phoenix 28
Bremen 26
Buffalo 26
Jacksonville 26
Princeton 26
Redondo Beach 26
Ann Arbor 25
Milan 25
Tianjin 24
Medford 23
Des Moines 22
Shanghai 21
Chicago 20
Columbus 20
London 20
Helsinki 19
Denver 18
Montreal 18
Tashkent 18
Turku 18
Chennai 17
Frankfurt am Main 17
Rio de Janeiro 17
Brasília 16
Brooklyn 16
Belo Horizonte 15
Guangzhou 15
Orem 15
Boardman 14
Brussels 14
Lappeenranta 14
Nuremberg 14
Amsterdam 13
Houston 13
Atlanta 11
Campinas 11
Boston 10
Cambridge 10
Manchester 10
Mexico City 10
Porto Alegre 10
Springfield 10
Tokyo 10
Catania 9
Düsseldorf 9
Hangzhou 9
Pune 9
Quito 9
San Francisco 9
San Marcellino 9
Stockholm 9
Washington 9
Hillsboro 8
Jakarta 8
Nairobi 8
Nanjing 8
Newark 8
Salvador 8
Ankara 7
Da Nang 7
Goiânia 7
Hyderabad 7
Johannesburg 7
Kuala Lumpur 7
Los Lunas 7
New Delhi 7
Seattle 7
Shenzhen 7
Baghdad 6
Baku 6
Curitiba 6
Fort Worth 6
Kingston 6
Mumbai 6
Philadelphia 6
Totale 5.282
Salva come PNG Salva come JPEG
Nome #
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI 308
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 259
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 214
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 194
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 189
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 187
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 187
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 186
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 184
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 181
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 177
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 171
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 166
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 163
P1468Non-invasive myocardial work indices in ischemic heart disease 162
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 161
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 159
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 155
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 149
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 143
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 138
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 138
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 136
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 133
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 130
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 129
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 129
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 125
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 124
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 124
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 122
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 120
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 118
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 118
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 116
Left Main Coronary Artery 116
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 114
The High Bleeding Risk Patient with Coronary Artery Disease 113
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 112
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 110
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 110
Mental health status and sexual habits in young patient after acute coronary syndrome 107
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 106
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 104
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 103
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 102
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 99
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 99
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 99
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 98
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 98
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 94
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 91
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 88
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 88
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 87
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 87
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 85
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 85
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 82
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 81
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment 80
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 78
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 77
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 77
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 75
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol 75
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 74
Catheter-based techniques for pulmonary embolism treatment 68
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 66
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization 64
Vacuum-assisted thrombectomy of massive inferior vena cava thrombosis 55
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 53
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care 51
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 49
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 47
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 46
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 45
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 42
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 38
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 37
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 35
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 32
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke 31
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 31
Transfusion and Mortality After Transcatheter Aortic Valve Replacement 30
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 30
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 29
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 28
null 28
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score 27
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 26
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 25
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 25
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies 25
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19 24
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 24
Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE) 23
Inhibidores selectivos de la recaptacion de serotonina y riesgo hemorragico tras ICP. Un estudio con puntuacion de propension 22
DAPT After PCI in High Bleeding Risk 21
Totale 9.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022190 0 0 15 6 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024340 21 27 17 39 24 73 70 16 8 21 1 23
2024/20251.694 20 14 16 150 110 135 74 220 368 126 155 306
2025/20265.713 343 313 407 417 463 1.171 619 715 652 315 152 146
2026/2027722 434 233 55 0 0 0 0 0 0 0 0 0
Totale 10.106